多囊卵巢综合征（PCOS）的分子研究
Molecular Research on Polycystic Ovary Syndrome (PCOS).
作者信息
Daniele Simona, Chelucci Elisa, Scarfò Giorgia, Artini Paolo Giovanni
机构信息
Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Division of General Medicine, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
出版信息
Biomedicines. 2023 May 4;11(5):1358. doi: 10.3390/biomedicines11051358.
Abstract
Polycystic ovary syndrome (PCOS) is an endocrine systemic disorder with a prevalence of between 5% and 20% that commonly affects childbearing-aged women [...].
摘要
多囊卵巢综合征（PCOS）是一种内分泌系统性疾病，患病率在5%至20%之间，通常影响育龄妇女[...]。
相似文献
1
Molecular Research on Polycystic Ovary Syndrome (PCOS).多囊卵巢综合征（PCOS）的分子研究
Biomedicines. 2023 May 4;11(5):1358. doi: 10.3390/biomedicines11051358.
2
Binge Eating Disorder-The Point Prevalence among Polish Women with Polycystic Ovary Syndrome and Validity of Screening Tool for This Population.暴食障碍-多囊卵巢综合征波兰女性中的时点患病率和针对该人群的筛查工具的效度。
Int J Environ Res Public Health. 2022 Dec 29;20(1):546. doi: 10.3390/ijerph20010546.
3
Metabolic Features of Women With Polycystic Ovary Syndrome in Latin America: A Systematic Review.拉美多囊卵巢综合征女性的代谢特征：系统评价。
Front Endocrinol (Lausanne). 2021 Oct 19;12:759835. doi: 10.3389/fendo.2021.759835. eCollection 2021.
4
Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.六味地黄丸通过 PI3K/Akt 信号通路改善胰岛素敏感性，从而缓解多囊卵巢综合征。
J Ethnopharmacol. 2020 Mar 25;250:111965. doi: 10.1016/j.jep.2019.111965. Epub 2019 Jun 8.
5
The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.根据鹿特丹标准与包括抗苗勒管激素在内的修订标准，正常人群中多囊卵巢综合征的患病率。
Hum Reprod. 2014 Apr;29(4):791-801. doi: 10.1093/humrep/det469. Epub 2014 Jan 16.
6
Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.多囊卵巢形态学与多囊卵巢综合征的诊断：应用聚类分析重新定义卵泡计数和血清抗苗勒管激素的临界值。
Hum Reprod. 2017 Aug 1;32(8):1723-1731. doi: 10.1093/humrep/dex226.
7
Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome.多囊卵巢综合征中子宫内膜容受性异常与氧化应激
Front Pharmacol. 2022 Jul 25;13:904942. doi: 10.3389/fphar.2022.904942. eCollection 2022.
8
The immune system's role in PCOS.免疫系统在 PCOS 中的作用。
Mol Biol Rep. 2022 Nov;49(11):10689-10702. doi: 10.1007/s11033-022-07695-5. Epub 2022 Jun 25.
9
Prevalence, clinical characteristics, and reproductive outcomes of polycystic ovary syndrome in older women referred for tertiary fertility care.转诊至三级生殖医学中心的老年女性多囊卵巢综合征的患病率、临床特征及生殖结局
Arch Gynecol Obstet. 2018 Apr;297(4):1037-1042. doi: 10.1007/s00404-017-4642-z. Epub 2017 Dec 30.
10
Psychiatric disorders in women with polycystic ovary syndrome.多囊卵巢综合征女性的精神障碍
Psychiatr Pol. 2019 Aug 31;53(4):955-966. doi: 10.12740/PP/OnlineFirst/93105.
引用本文的文献
1
PGD: Shared gene linking polycystic ovary syndrome and endometrial cancer, influencing proliferation and migration through glycometabolism.PGD：多囊卵巢综合征和子宫内膜癌相关的共享基因，通过糖代谢影响增殖和迁移。
Cancer Sci. 2024 Sep;115(9):2908-2922. doi: 10.1111/cas.16212. Epub 2024 Jul 9.
2
Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.通过通路富集分析和枢纽基因- microRNA网络揭示多囊卵巢综合征（PCOS）的关键生物标志物和治疗药物
Iran J Pharm Res. 2023 Nov 20;22(1):e139985. doi: 10.5812/ijpr-139985. eCollection 2023 Jan-Dec.
本文引用的文献
1
Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent.抗苗勒管激素与女性多囊卵巢综合征及其男性对应病症
Biomedicines. 2022 Oct 7;10(10):2506. doi: 10.3390/biomedicines10102506.
2
Diabetes Mellitus Mediates Risk of Depression in Danish Women with Polycystic Ovary Syndrome-A National Cohort Study.糖尿病介导丹麦多囊卵巢综合征女性患抑郁症的风险——一项全国队列研究
Biomedicines. 2022 Sep 26;10(10):2396. doi: 10.3390/biomedicines10102396.
3
Level of Potassium Is Associated with Saturated Fatty Acids in Cell Membranes and Influences the Activation of the 9 and 13 HODE and 5 HETE Synthesis Pathways in PCOS.钾水平与细胞膜中的饱和脂肪酸相关，并影响多囊卵巢综合征中9-和13-羟基十八碳二烯酸（HODE）及5-羟基二十碳四烯酸（5-HETE）合成途径的激活。
Biomedicines. 2022 Sep 9;10(9):2244. doi: 10.3390/biomedicines10092244.
4
Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives.胰高血糖素样肽-1激动剂在多囊卵巢综合征中的治疗潜力：从当前临床证据到未来展望
Biomedicines. 2022 Aug 16;10(8):1989. doi: 10.3390/biomedicines10081989.
5
Putative Complementary Compounds to Counteract Insulin-Resistance in PCOS Patients.用于对抗多囊卵巢综合征（PCOS）患者胰岛素抵抗的潜在互补化合物。
Biomedicines. 2022 Aug 9;10(8):1924. doi: 10.3390/biomedicines10081924.
6
The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside-A Systematic Literature Review.微小RNA在多囊卵巢综合征中的转化作用：从实验台到临床——一项系统文献综述
Biomedicines. 2022 Jul 28;10(8):1816. doi: 10.3390/biomedicines10081816.
7
Sex Steroid Receptors in Polycystic Ovary Syndrome and Endometriosis: Insights from Laboratory Studies to Clinical Trials.多囊卵巢综合征和子宫内膜异位症中的性类固醇受体：从实验室研究到临床试验的见解
Biomedicines. 2022 Jul 14;10(7):1705. doi: 10.3390/biomedicines10071705.
8
The Role of Oxidative Stress in the Risk of Cardiovascular Disease and Identification of Risk Factors Using AIP and Castelli Atherogenicity Indicators in Patients with PCOS.氧化应激在多囊卵巢综合征患者心血管疾病风险中的作用以及使用致动脉粥样硬化指数（AIP）和卡斯泰利动脉粥样硬化性指标识别风险因素
Biomedicines. 2022 Jul 14;10(7):1700. doi: 10.3390/biomedicines10071700.
9
Role of Single Nucleotide Variants in the Gene in Adolescents with Polycystic Ovary Syndrome.单核苷酸变异在青少年多囊卵巢综合征相关基因中的作用
Biomedicines. 2022 Jul 13;10(7):1688. doi: 10.3390/biomedicines10071688.
10
An Ovarian Steroid Metabolomic Pathway Analysis in Basal and Polycystic Ovary Syndrome (PCOS)-like Gonadotropin Conditions Reveals a Hyperandrogenic Phenotype Measured by Mass Spectrometry.基础状态和多囊卵巢综合征（PCOS）样促性腺激素状态下的卵巢类固醇代谢组学通路分析揭示了通过质谱检测的高雄激素血症表型。
Biomedicines. 2022 Jul 8;10(7):1646. doi: 10.3390/biomedicines10071646.
Zotero 插件